Dec 7 (Reuters) - Britain's FTSE 100 .FTSE index is seen opening 4 points
lower at 6,546 on Monday, according to financial bookmakers.
* ASTRAZENECA: Serum Institute of India, the world's largest vaccine
producer by volume, has sought emergency use authorization in the country for
AstraZeneca Plc's AZN.L COVID-19 vaccine candidate, its chief executive
officer said on Monday. * COVID-19: Britain is preparing to become the first country to roll out the
Pfizer/BioNTech COVID-19 vaccine this week, initially making the shot available
at hospitals before distributing stocks to doctors' clinics, the government said
on Sunday. * CONSUMER SPENDING: Bank of England Chief Economist Andy Haldane said
consumer spending in Britain has come back at a "real pace", according to a
British newspaper. * BREXIT: Britain and the European Union will make a last-ditch attempt to
strike a post-Brexit trade deal this week, with probably just days left for
negotiators to avert a chaotic parting of ways at the end of the
year. * GOLD: Gold prices steadied as grim U.S. jobs data bolstered hopes for more
fiscal stimulus, although optimism around coronavirus vaccine rollouts kept
gains in check. * OIL: Oil prices fell as a continued surge in coronavirus cases globally
forced a series of renewed lockdowns, including strict new measures in Southern
California in the United States, the world's top oil consumer. * The UK blue-chip index .FTSE closed 0.9% higher on Friday as a jump in
oil prices boosted energy stocks, while investors remained focussed on Brexit
trade talks with only four weeks left for Britain's transition period out of the
bloc to end. UK CORPORATE DIARY:
Ted Banker Plc TED.L HY earnings
Imimobile Plc IMOI.L HY earnings
* For more on the factors affecting European stocks, please click on:
LIVE/
TODAY'S UK PAPERS
> Financial Times PRESS/FT
> Other business headlines PRESS/GB